Registration of Urothelial Tumours in Cancer Registries: How to Improve and Make It More Useful?

Laetitia Daubisse-Marliac, Pascale Grosclaude, Marià Carulla, David Parada, Loreto Vilardell, Alberto Ameijide, Rafael Marcos-Gragera and Jaume Galceran
Additional contact information
Laetitia Daubisse-Marliac: Claudius Regaud Institute, IUCT-O, Tarn Cancer Registry, CEDEX 9, 31059 Toulouse, France
Pascale Grosclaude: Claudius Regaud Institute, IUCT-O, Tarn Cancer Registry, CEDEX 9, 31059 Toulouse, France
Marià Carulla: Cancer Epidemiology and Prevention Service, Salut Sant Joan de Reus Baix Camp, Pere Virgili Health Research Institute (IISPV), Rovira i Virgili University, 43204 Reus, Catalonia, Spain
David Parada: Anatomic Pathology Department, Salut Sant Joan de Reus Baix Camp, Pere Virgili Health Research Institute (IISPV), Rovira i Virgili University, 43204 Reus, Catalonia, Spain
Loreto Vilardell: Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology—Girona Biomedical Research Institute, 17004 Girona, Spain
Alberto Ameijide: Cancer Epidemiology and Prevention Service, Salut Sant Joan de Reus Baix Camp, Pere Virgili Health Research Institute (IISPV), Rovira i Virgili University, 43204 Reus, Catalonia, Spain
Rafael Marcos-Gragera: Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology—Girona Biomedical Research Institute, 17004 Girona, Spain
Jaume Galceran: Cancer Epidemiology and Prevention Service, Salut Sant Joan de Reus Baix Camp, Pere Virgili Health Research Institute (IISPV), Rovira i Virgili University, 43204 Reus, Catalonia, Spain

IJERPH, 2022, vol. 19, issue 5, 1-15

Abstract: Due to the differences in the definition, criteria of inclusion and coding of urothelial tumours (UTs), data of different cancer registries (CRs) are not comparable. The aim of this work is to study current practices of registration of UT in the European CR of the GRELL countries in order to propose new registration rules to correctly describe incidence and survival of progressive tumours like UT. A questionnaire was sent to 91 CRs to assess whether non-invasive (NI)UT, multiple UTs, UTs occurring outside or before the operating period and time between UTs are currently considered in tumour recording and reporting. All participating CRs ( n = 42) record a NI bladder UT in sole occurrence. In case of progressive bladder UT, 98% of the CRs record at least one NIUT but 19% don’t record the invasive progression. 17% of the CRs don’t record an invasive pelvic tumour that occurs after a NI bladder UT. 19% of the CRs don’t record an invasive bladder UT that followed a NI tumour occurring outside the zone or period of time. The recording of two synchronous UTs is carried out with a grouping topography for 36% of the CRs. The same analysis conducted on the reporting of the incidence of UT also shows heterogeneity. We conclude that there is an urgent need to define clear rules for the registration of UT.

Keywords: urothelial tumours; bladder cancer; recording; reporting; registration practices; cancer registry (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/5/2714/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/5/2714/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:5:p:2714-:d:758963

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().